Sarcoma Alliance For Research Through Collaboration

This study tests a combination of two drugs (regorafenib and nivolumab) in people with osteosarcoma, a type of bone cancer, that has returned or not responded to prior treatment. The goal is to see if this combination can stop the cancer from growing for at least 4 months longer …

This study tests a combination of two drugs, bezuclastinib and sunitinib, in 40 adults with advanced gastrointestinal stromal tumors (GIST) that continued to grow despite sunitinib treatment alone. The goal is to see if the combination can slow cancer progression and to identify …